XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Segment Information (Tables) | 3 Months Ended
--- | ---
Mar. 30, 2024
Segment Reporting [Abstract] |
Schedule of Segment Information | The following tables present the Company's segment information for the 13 weeks ended March 30, 2024 and April 1, 2023 (in $000's):
| Thirteen Weeks Ended
| March 30, 2024 |  | April 1, 2023
Revenues |  |  |
Biotechnology | $ | — |  |  | $ | — |
Discontinued operations | — |  |  | 3,795 |
Total Revenues | $ | — |  |  | $ | 3,795 |
Gross profit |  |  |
Biotechnology | $ | — |  |  | $ | — |
Discontinued operations | — |  |  | (197) |
Total Gross profit | $ | — |  |  | $ | (197) |
Operating loss |  |  |
Biotechnology | $ | (1,806) |  |  | $ | (1,099) |
Discontinued operations | — |  |  | 14,158 |
Total Operating loss | $ | (1,806) |  |  | $ | 13,059 |
Depreciation and amortization |  |  |
Biotechnology | $ | — |  |  | $ | 364 |
Discontinued operations | — |  |  | 96 |
Total Depreciation and amortization | $ | — |  |  | $ | 460 |
Interest (income) expense, net |  |  |
Biotechnology | $ | 252 |  |  | $ | (475) |
Discontinued operations | — |  |  | 181 |
Total Interest expense, net | $ | 252 |  |  | $ | (294) |
Net income (loss) before income taxes |  |  |
Biotechnology | $ | (2,219) |  |  | $ | (889) |
Discontinued operations | — |  |  | 13,976 |
Total Net income before income taxes | $ | (2,219) |  |  | $ | 13,087 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration